ArticleScientific reports2017

SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression.

R Berzaghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.